期刊文献+

小儿实体肿瘤治疗的现状 被引量:4

Current status of solid tumor treatment in children
下载PDF
导出
摘要 小儿实体肿瘤的治疗是提高恶性实体瘤生存率的关键之一。肿瘤的外科处理除挽救生命外,主要考虑到生活质量。化疗是选择有效合理联合应用抗癌药,且副作用小,重点之一是化疗药物耐药性的研究;在儿童中尽量少用放疗,如必需应用,也需注意防护与适当剂量,现介入性治疗和术中放疗已逐渐开展。治疗实体瘤的新措施还包括生物反馈修饰剂、诱导肿瘤分化、靶向药物和单克隆抗体等。 Solid tumors treatment in children is one of the crucial factors to increase the survival rate of malignant tumors. In addition to saving lives, surgical treatment of tumors can also improve quality of life in patients. Chemotherapy is a reasonable choice because of its anti-cancer action with few side effects. The focus is the drug resistance studies of the chemotherapy. Radiotherapy is not recommended in childhood solid tumor treatment. If it is required, protection and appropriate dosage should be paid attention to. Interventional therapy and intraoperative radiotherapy has been gradually carried out. New measures of solid tumor treatment also include biofeedback modifier, induced tumor differentiation, targeting drugs and monoclonal antibodies, etc.
作者 施诚仁
出处 《临床儿科杂志》 CAS CSCD 北大核心 2008年第11期915-917,共3页 Journal of Clinical Pediatrics
关键词 儿童 实体瘤 治疗 children solid tumor treatment
  • 相关文献

参考文献10

  • 1Folkman J. Angiogenesis in cancer: vascular, rheumatoik and other disease [J]. Nat Med, 1995,1 (1) :27-31.
  • 2Li HR,Shagisultanova EL,Yamashita K, et al. Hypersensitivity of tumor cell with microsatellite instability to DNA double strand break producing chemotherapeutic agent bleomycin [ J ]. Cancer Res, 2004,64 (14) : 4760-4767.
  • 3施诚仁.小儿实体肿瘤的外科治疗.儿童肿瘤,2007,6(2):4-5.
  • 4Saran F. New technology for radiotherapy in pediatric oncology [J]. Eur J Cancer,2004,40(14):2091-2105.
  • 5Kavangh M, Quellet JF. Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraeperative intraperitoneal chemotherapy [ J ]. Bull Cancer, 2006,93 (9) : 867-874.
  • 6Xuewu J, Jianhong L, Xianliang H, et al. Combined treatment of hepatoblastoma with transcatheter arterial chemoembolization and surgery [J]. Pediatr Hematol Oncol,2006,23 ( 1 ) : 1-9.
  • 7翟宝进,伍烽.质膜蛋白与肿瘤多药耐药现象[J].国外医学(分子生物学分册),2003,25(5):308-311. 被引量:2
  • 8汤永民.肿瘤干细胞与其靶向治疗.儿童肿瘤,2007,6(2):1-3.
  • 9Brinkmann U. Recombinant antibody fragments and immunotoxin fusions for cancer therapy [J]. In Vivo,2000, 14(1) :21-27.
  • 10Eikenes L, Bruland OS, Brekken C, et ol. Colleagenase increase the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts [J ]. Cancer Res, 2004,64 (14) :4768-4773.

二级参考文献20

  • 1张欣 等.华西医科大学学报,1999,30(4):360-360.
  • 2Gottesman MM et al. Cancer, 2002 ; 2 (1) : 48.
  • 3Grandjean F et al. Anticancer Drugs, 2001; 12(3) : 247.
  • 4Dean M et al. J Bioenerg Biomember, 2001;33(6):475.
  • 5Hatanaka H et al. Anticancer Res,2001; 21(2A) :879.
  • 6Homem de Bittencourt PI Jr et al. Biochem Pharmacol,2001;62(7):811.
  • 7Ohno N et al. Blood, 2001; 98(4):1160.
  • 8Olaf Van Tellingen. Toxicology Letters, 2001 ; 120 : 31.
  • 9Koki AT et al. Expert Opin Investig Drugs, 1999; 8(10).
  • 10Uemaisu T et al. Int Cancer,2001 ;92(2) : 187.

共引文献1

同被引文献31

  • 1刘平,葛迎春,马天舒.四逆汤类方药理研究进展[J].辽宁中医杂志,2007,34(2):248-251. 被引量:19
  • 2史学,祝秀丹,王焕民,秦红,李海天,成海燕.中医扶正健脾法配合化疗治疗小儿实体肿瘤的临床观察[J].中国中西医结合杂志,2007,27(6):542-545. 被引量:14
  • 3李华斌,李玲,党群,邹黎,朱玲.彩超引导下自动活检枪在乳腺包块穿刺活检中的应用[J].西南国防医药,2007,17(4):472-473. 被引量:5
  • 4Rowe PM. Comptothecins:new enthusiasm for an old rug [J]. Lancet, 1996,347(9005):892.
  • 5Bouche O, Raoul JL, Bonnetain F, et al. Randomized multicenter phase I! trial of a biweekly re gimen of fluorouraeil and leueovorin (LV5FU2), LV5FU2 plus cisplatin,or LV5FU2 plusirinotecan in pa- tients with previously untreated metastatic gastric canoe r:a Federa- tion Francophone de Cane erologie Digestive Group Study -FECD9803[J]. J Clin OncoI, 2004,22 (21):4319-4328.
  • 6Chfibbaro S, Benvenuti L, Caprio A, et al. Temozolomide as first line agent in treating high grade gliomas: Phase II study [J]. Can eer, 2004,100 (3):605.
  • 7Lars M. Wagner, Judith G. et al. Phase I Trial of Oral Irinot~can and Temozolomide forChildrenWith Relapsed High-Risk Neuroblastoma: A NewApproach to Neuroblastoma Therapy Consortium Study [J]. J Clin OncoI, 2009,27(8): 1290-1295.
  • 8Lars M.Wagner, et al. Phase I Trial of Temozolomide and Protracted Irinotecan in Pediatric Patients with Refractory Solid Tumors [J]. Clinical cancer research, 2004,(10):840-847.
  • 9Pourquier P, Waltman JL, Urasaki Y, et al. Topoisomerase 1-mediated cytotoxicity of N-methyl-N -nitro-N-nitroguanidine: Trapping of topoisomerase I by the O6-methylguanine. Cancer Res, 2001,61: 53-58.
  • 10Houghton PJ, Stewart CF, Cheshire PJ, et al. Antitumor activity of temozolomide combined with irinotecan is partly independent of O6-methylguanine-DNA methyltransferase and mismatch repair phe- notypes in xenograt~ models[J]. Clin Cancer Res, 2000,6:4110-4118.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部